
Aastha Chokshi, MD
@achokshi1
GI Fellow @MarylandGastro | #EBGI ambassador @ACG_EBGI | @BrownMedicine Internal Medicine ‘24 | @Rutgers_NJMS ‘21 | @Princeton '17
ID: 1293709073460928514
13-08-2020 00:41:02
134 Tweet
235 Followers
209 Following



Is there a higher risk of esophageal adenocarcinoma 🦀 in patients with non-erosive GERD 🔥after a normal 🔦? Check out this tweetorial👇 by Kuntal Bhowmick, MD to find out! Evidence-Based GI: An ACG Publication (EBGI) ACG


1/ ⏰ for #EBGI Tweetorial🧵w/ Eleazar Montalvan “Monte” & Benjamin Clement, MD! “Continued Treatment With Tirzepatide Is Necessary to Maintain Weight Loss” 📜Summary: shorturl.at/pzES5 🎧 : shorturl.at/gCDO7 📰 : shorturl.at/gjIK3 #GITwitter #Medtwitter


All adults age 45+ should be 🔦 for CRC. However, when do you 🛑 CRC screening and what is the role of overall health status ⚕️ and life expectancy 💀 in making this decision? Find out in our tweetorial👇! #ColorectalCancerAwarenessMonth #EBGIxCRC Evidence-Based GI: An ACG Publication (EBGI) ACG



Benedict Ezeani Evidence-Based GI: An ACG Publication (EBGI) ACG Asad ur Rahman, MD, FACP Debbie Shawcross George Ioannou Heather L Stevenson, MD, PhD Hirsh D. Trivedi, MD, MS Jeremy Louissaint ABGH Kevan Salimian, MD, PhD HEPATOLOGY Journal Lauren Feld Matt Townsend Meagan Gray Michael Li, MD, MPH Nancy Reau Patricia Jones Rashmi Advani, MD, ABOM Rebekah Russell Dr. Bobby Brown Keith Siau @RotonyaC @spaulliver Taseen Syed MD, FACP Kavya Reddy MD Samuel A Schueler, MD Edward Barnes MD MPH Zubair Malik Basile Njei, MD, MPH, PhD Tinsay Woreta Lizzie Aby, MD Bincy Abraham, MD, MS Jean-Paul Achkar Yasmin Alishahi MD, FACG, AGAF Millie Long Matthew Whitson MD MSEd Justin Kupec Mark C. Mattar, MD Doug Simonetto, MD Adam C. Ehrlich, MD, MPH, FACG Farah Monzur, MD, FACG, FASGE Mayo Clinic Gastroenterology & Hepatology Women In Endoscopy | WIE Yara Sarkis, MD Liver Fellow Network World Gastroenterology Organisation (WGO) Mark B. Pochapin, MD 👩⚕️ Laura T 👩⚕️ Emory Gastroenterology and Hepatology Fellowship 6/🔎 Results ✅Patients with T2DM🍬 treated with GLP-1 receptor agonists were 🔽 likely to develop serious liver events compared to those receiving DPP4 inhibitors 💊 (aHR0.85; 95% CIs 0.75-0.97)


1/ ⏰ for #EBGI 🧵w/ Kuntal Bhowmick, MD! “Cell-free DNA Blood Test for CRC Screening: A Promising Development Won’t “Eclipse” Current Tools” 📜 - shorturl.at/0A0Uo 🎧 - shorturl.at/ojdTj 📰 - shorturl.at/05KQz #GITwitter



1/ ⏰ for #EBGI Tweetorial🧵 w/Benjamin Clement, MD! “Oral Vonoprazan for Prevention of High-Risk Peptic Ulcer Rebleeding: A Better Alternative Than IV PPIs? 📜 Summary: shorturl.at/d6yjL 🎧 shorturl.at/b6MJC 📰 shorturl.at/ZfZzA





Grateful to have had the opportunity to meet and reconnect with mentors and friends from Brown IM Residency at #ACG2024! The Warren Alpert Medical School



1/ ⏰ for #EBGI Tweetorial🧵w/ Aastha Chokshi, MD! “Decreasing Cirrhosis Risk in MASLD: Don’t Drink Alcohol!” 📜Summary: shorturl.at/Be3iX 🎧shorturl.at/uhWEa 📰 shorturl.at/q0Of1 #GITwitter
